0001179110-19-000574.txt : 20190108 0001179110-19-000574.hdr.sgml : 20190108 20190108173211 ACCESSION NUMBER: 0001179110-19-000574 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181026 FILED AS OF DATE: 20190108 DATE AS OF CHANGE: 20190108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hack Andrew A. F. CENTRAL INDEX KEY: 0001657434 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 19516783 MAIL ADDRESS: STREET 1: 300 THIRD STREET, FIRST FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2018-10-26 2018-10-30 0 0001650664 Editas Medicine, Inc. EDIT 0001657434 Hack Andrew A. F. C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 0 1 0 0 Chief Financial Officer Common Stock 2018-10-26 4 M 0 6000 3.23 A 6000 D Stock Option (right to buy) 3.23 2018-10-26 4 M 0 6000 0 D 2025-07-13 Common Stock 6000 124427 D Stock Option (right to buy) 6.48 2025-09-13 Common Stock 23513 23513 D The Reporting Person is filing this amended Form 4 to amend the Form 4 filed by the Reporting Person with the SEC on October 30, 2018, which inadvertently reported the exercise of a different stock option held by the Reporting Person. This amended Form 4 now reflects the correct information regarding the option that was exercised. The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 29, 2018. This option was granted on July 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. The Form 4 filed by the Reporting Person with the SEC on October 30, 2018 erroneously reported this option as having been exercised. This amended Form 4 now includes the correct information regarding the portion of this option that was outstanding as of the date of the transactions reported on this amended Form 4. This option was granted on September 14, 2015 and is scheduled to vest over four years, with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019. /s/ Andrew Hack 2019-01-08